test

Aquis weekly movers: Incanthera orders doubled

Skincare treatments developer Incanthera (LON: INC) says the first production order for its Skin + CELL products from Marionnaud has been doubled to 100,000 units. The launch will be in September. The previous figure was already higher than the initial order and the revenues from the order will be £4m. Future production orders could be even larger. This will help group revenues for the year to March 2025 to be more than £10m. This has enabled Incanthera to raise £4.1m from a share issue at 15p/share to cover additional working capital. The share price jumped 21.1% to 23p. Lupus treatment developer ImmuPharma (LON: IMM) raised £1.5m from the sale of its 9.98% stake in Incanthera, which was valued at £600,000 at the end of 2023, although it retains warrants.

TruSpine Technologies (LON: TSP) is talking to several potential commercial partners for its medical device technology, where the regulatory process is ongoing. The new board has improved relations with the inventor of the spinal stabilisation device IP. The investor relations website has been relaunched and a new medical advisory board will be put in place. The share price improved 14% to 3.25p.  

- Advertisement -

Bitcoin mining company Vinanz Ltd (LON: BTC) has received the first 20 bitcoin mining machines for its central Iowa facility. The share price edged up 0.98% to 12.875p.

FALLERS

Rogue Baron (LON: SHNJ) consolidated six existing shares into one new share following its AGM. The share price of the spirits brands owner fell 38.5% to 1.2p.

CBD products supplier Voyager Life (LON: VOY) says another potential merger has fallen through. This follows the ending of the Northern Leaf deal. This has left Voyager Life short of cash. The business operations are being reviewed and there are talks about funding. The company has been winning new business and there are signs of an improvement in the retail stores. The share price slumped 35.3% to 2.75p.

- Advertisement -

Psych Capital has changed its name to Shortwave Life Sciences (LON: PSY). The share price dipped 8% to 2.3p.

Invinity Energy Systems (LON: IES) has leased an additional manufacturing facility in Motherwell. This should become operational in the third quarter and capacity should be more than 500MWh of energy storage per year. The Bathgate facility will also be upgraded. The share price slid 4.44% to 21.5p.

KR1 (LON: KR1) has invested $1m into the Avail Web3 infrastructure project in return for 12.5 million AVAIL tokens. The share price decreased 1.9% to 77.5p.

Arbuthnot Banking Group (LON: ARBB) has completed the renewal of its subordinated loan, which is classified as Tier 2 capital. The loan was increased by £1m to £26m and lasts until June 2034. The share price declined 1.29% to 960p.

Latest News

Subscribe to the UK Investor Magazine email newsletter

Register for our free email newsletter and receive the latest investment news, podcasts, event information and offers.

More Articles Like This

Tagdiv Cloud library - template content.